Zai Lab Pays $15 Million for China Rights to Electric Field Therapy for Brain Cancer Sep 13, 2018 Life Science
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer Sep 11, 2018 Life Science
Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal Sep 11, 2018 Life Science
Miracor Medical closes final tranche of Series-D, bringing the round to €30M Sep 5, 2018 Life Science
